UT San Antonio team studies circadian disruption’s role in Alzheimer’s disease

April 21, 2026

The University of Texas at San Antonio was recently awarded a highly competitive Alzheimer’s Association research grant to investigate the gene-environment interaction and how it may contribute to an increased risk for Alzheimer’s disease. The grant will begin in April and provides $200,000 to fund the study over the next three years.

Insomnia and sleep disorders



Large rapamycin clinical trial launches at UT Health San Antonio

March 16, 2026

A drug once known almost exclusively for preventing organ transplant rejection is now at the center of a National Institute on Aging-funded clinical study at UT Health San Antonio, to determine how rapamycin should be used in older adults to promote healthy aging.




UT San Antonio advances in national Blue Ridge rankings

March 9, 2026

In its first appearance in the national standings as a united institution, UT San Antonio posted a strong performance in the latest rankings from the Blue Ridge Institute for Medical Research. The Blue Ridge Institute is an independent nonprofit organization that compiles annual funding data from the National Institutes of Health.